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Objectives. Little is known about the significance of Streptococcus G or C colonization in pregnant women. The objective of this
study was to assess whether vaginal Streptococcus group G or C colonization detected in late pregnancy increases the infectious
morbidity of the mother or newborn. Methods. A total of 15,114 rectovaginal cultures taken at 35–37 weeks of pregnancy were
analyzed at Tampere University Hospital, Finland, between 2012 and 2014. From this laboratory data, all Streptococcus G or C-
positive cultures were included to study maternal and neonatal infectious morbidity after delivery. This study population was
compared to women with a positive Streptococcus B culture and to women with a negative culture. Results. The prevalence of
Streptococcus G or C colonization was 2.9%. Significantly more postpartum endometritis was found in this study group. No
association was found between colonization and neonatal bacteremia. Conclusions. Streptococcus G or C colonization is associated
with postpartum endometritis. More research is needed to clarify if antibiotic prophylaxis is reasonable for this group during
delivery.
1. Introduction
Streptococcus dysgalactiae subspecies equisimilis (SDSE, Strep-
tococcus group C or G) belongs to the group of beta-
hemolytic Streptococci. Groups C and G Streptococci are
often also referred to as pyogenic Streptococci because they
are genetically close to Streptococcus pyogenes [1]. Van-
damme et al. [2] divided Streptococcus dysgalactiae into
two subspecies: SDSE was proposed for human groups and
Streptococcus dysgalactiae subspecies dysgalactiae (SDSD) for
strains of animal origin. SDSE have been identified as part of
the normal flora of the human respiratory, gastrointestinal,
and female genital tracts. Thus, for many years colonization
by these bacteria has been considered harmless. However,
the pathogenicity of SDSE has now been better recognized.
Recent epidemiological studies have shown that SDSE causes
a variety of diseases similar to those caused by Strepto-
coccus pyogenes. Skin and soft tissue infections range from
superficial wound infections to severe invasive infections,
such as necrotizing fasciitis and life-threatening Streptococ-
cal toxic shock syndrome (STSS) and bacteremia [3–5]. In
2009, Broyles et al. [6] reported almost 500 invasive SDSE
infections in a large population-based epidemiological study
in North America. In this study, 64% of the patients were
males and 87% of the patients had underlying diseases. The
mortality rate to bacteremia was 12%, similar to that reported
elsewhere [7, 8]. In Finland, a 2.7-fold rise in Streptococcus
G or C bacteremia was found among adult patients during a
ten-year period between 1995 and 2004.This research showed
that a disruption of the cutaneous barrier was an important
predisposing factor [9, 10]. In addition, an association has
been found between bacteremia and underlying conditions
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such as alcoholism, diabetes mellitus, immunosuppression,
and advanced age [6, 11, 12].
Although SDSE is increasingly recognized as an impor-
tant human pathogen, there is only limited information
about the clinical role of SDSE colonization in pregnant
women. As there are several changes in the immune system
of pregnant women, SDSE colonization could be potentially
pathogenic for pregnant women and newborns. Lu et al.
[13] have reported on a surgical-site infection due to SDSE
after cesarean section in a patient whose genital tract was
colonized with Streptococcus G. In another case report
[14], an otherwise healthy nonimmunocompromised young
adult woman at 17 weeks of gestation developed meningitis
caused by SDSE. It was thought that Streptococcal meningitis
was acquired via transient colonization of the nasopharynx
followed by bacteremia and invasion of the central nervous
system. Faix et al. [15] found group C Streptococci in the
cerebrospinal fluid of a newborn infant whose mother had
chorioamnionitis during the delivery. In 1985, Vartian et al.
[11] reported four cases of puerperal sepsis among fifty-seven
cases of group G Streptococcal infection. In these and in the
majority of other reported cases of puerperal infections due
toGStreptococci, patients recovered promptly after antibiotic
therapy [12]. Despite the increasing use of antibiotics, Strep-
tococcus B and Streptococci G and C have remained sensitive
to penicillin and other beta-lactam antibiotics [16].
The aim of this study was to determine the proportion of
SDSE colonization at 35−37 weeks of gestation from 15,144
rectovaginal swab cultures and to assess the rate of early
maternal and neonatal postpartum infections associated with
SDSE colonization compared to patients with a positive
Streptococcus B culture or a negative culture.
2. Materials and Methods
Tampere University Hospital is the tertiary care hospital for
the ca. 524 700 inhabitants of Pirkanmaa Health District.
There are about 5300 deliveries at the hospital annually.
Universal screening for group B Streptococci was started
in the hospital’s catchment area in 2012. Laboratory testing
primarily analyzes the colonization of group B, but beta-
hemolytic Streptococci from other Lancefield groups, includ-
ing C and G, are also revealed. All cases of maternal SDSE
colonization based on a rectovaginal culture between January
1, 2012, and December 31, 2014, were identified from the
laboratory database. The cultures were taken at 35–37 weeks
of gestation using one swab from distal part of vagina,
perineal area, and anus.The swabwas swept first in the vagina
and then the same swab was swept along the perineal area to
the anus.
After the exclusion of cases with multiple colonization by
both Streptococcus B and either Streptococcus C or Strep-
tococcus G, there were 421 Streptococcus G or C-positive
cultures in the final analyses. For these cases, the next group
B Streptococci (GBS) colonization and the next negative
culture were selected from the database to form two control
groups. Thus, the entire study material consisted of 1263
women, whose rectovaginal culture was either Streptococcus
C or Streptococcus G only, Streptococcus B only or negative,
and their 1277 newborns. The maternal characteristics and
early maternal and neonatal infections after delivery of the
three groups were compared. Neonatal and obstetrics data,
including discharge diagnoses, infection register data, and
laboratory files for any culture-positive cases, were retrieved
from the hospital’s computerized databases.
Streptococcus B-positive mothers received prophylactic
antibiotic therapy, which at our medical center is routinely
penicillin G administered intravenously every fourth hour
during labor. The groups with negative cultures or SDSE
colonization were instructed to receive antibiotics only if
there were signs of clinical chorioamnionitis during the
delivery: presence of fever, fetal tachycardia, or laboratory
findings suggesting infection. The most common antibiotic
treatment for infection was cefuroxime or penicillin G com-
bined withmetronidazole intravenously.Women undergoing
cesarean delivery were routinely given intraoperative antibi-
otic prophylaxis, usually cefuroxime 1.5 g intravenously. In
postpartum endometritis, the routine intravenous antibiotic
treatment was cefuroxime 1.5 g and metronidazole 500mg
three times per day.Themost frequently used oral antibiotics
were cephalexin 500mg and metronidazole 500mg (three
times per day for 7–10 days).
2.1. Laboratory Analysis. Specimens were inoculated onto
selective screening plates for beta-hemolytic Streptococci
(blood agar base with 5% sheep’s blood and a colistin and
oxolinic acid supplement (LabM, Lancashire, UK)). Selective
plates were incubated in 5% carbon dioxide for 24 hours.
The Lancefield serogroups of typical beta-hemolytic colonies
from selective plates were defined by latex agglutination using
the Streptex latex test system (Remel Europe Ltd., Dartford,
UK).MALDI-TOFMS (bioMe´rieux) was used to confirm the
identification of Streptococci
2.2. Statistical Analyses. Statistical analyses were conducted
using SPSS software (IBM SPSS Statistics for Windows,
Version 23.0). ANOVA or the Kruskall–Wallis test was used
to test differences in mothers’ age and body mass index
(calculated asweight in kilograms divided by height inmeters
squared) between the three study groups (SDSE, Streptococ-
cus B, and negative culture), depending on whether the data
had a normal or skewed distribution. The chi-squared test
or Fisher’s exact test was used to test differences between the
three groups for the categorical variables. A 𝑝 value of <0.05
was considered statistically significant.
2.3. Ethical Approval. The study protocol was approved by
the PirkanmaaHospital District’s ethical committee (decision
R15517S, 19th March 2015).
3. Results
The swab cultures were taken from 94% of pregnant woman,
producing 15,144 samples. Out of these, 443 (2.9% of all
samples) were Streptococcus G or C-positive, 2957 (19.5%
out of all samples) were Streptococcus B-positive, and 11,
744 (77,5%) were negative. There were 22 samples, in which
both StreptococcusG or C and Streptococcus Bwere positive;
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Table 1: Selected clinical characteristics and demographics of the study population. Numbers are percentages or means (min, max).
Streptococcus G or C Streptococcus B Negative
𝑝-valueMothers 𝑛 = 421 𝑛 = 421 𝑛 = 421
Infants 𝑛 = 425 𝑛 = 424 𝑛 = 428
Variables
Age, years, mean (min, max) 30.3 (19,44) 30.3 (18,44) 30.2 (19,44) 0.973
BMI, median, kg/m2 (min, max) 23.5 (16,48) 23.5 (16,56) 22.9 (16,51) 0.114
BMI ≥ 30 16.2 18.6 18.1 0.051
Nulliparous 42.0 41.3 40.6 0.920
Current smoker 14.7 15.6 17.0 0.659
Caucasian 98.6 96.7 97.1 0.170
Gestational diabetes 16.7 19.2 17.8 0.496
Caesarean delivery 11.4 16.4 12.4 0.086
Anaemia 4.3 4.8 4.3 0.928
Antibiotic treatment during delivery∗ 35.6 92.4 20.4 <0.001
Blood loss ≥ 1000ml 5.9 6.9 7.4 0.675
Gestational age ≤ 37 weeks 4.8 2.9 5.7 0.115
Gestational age ≥ 42 weeks 6.2 3.1 2.1 0.007
Apgar score 1min < 3 0.5 1.2 0.9 0.527
Apgar score 5min < 7 1.6 1.9 2.3 0.795
BMI = bodymass index (calculated as persons weight in kilograms divided by square of height inmeters). ∗Including prophylactic antibiotics for Streptococcus
B colonization, treatment for suspected chorioamnionitis, and prophylactic antibiotics during cesarean section. Age and BMI were compared between three
groups using ANOVA or the Kruskall-Wallis test and the other variables with chi-squared test or Fisher’s exact test.
these cases were excluded, and all other Streptococcus G
or C-positive women remained as study group. From the
other groups, similar amount of women were randomly
selected into the two control groups. Selection of the study
cases is shown in Figure 1. The clinical characteristics and
demographic data are summarized in Table 1. There were no
differences between the subgroups in the mean age, body
mass index, or the cesarean section rate, but there were more
postterm pregnancies in the Streptococcus G or C group.
Of the 1263 study subjects, a total of 35 maternal infec-
tions were diagnosed after delivery. The most common puer-
peral infection was postpartum endometritis. The incidences
of any infections and endometritis in the SDSE colonization
group were significantly higher than in the other two groups
(5.7% versus 1.7% versus 1.0% for any puerperal infection in
the groups for SDSE, Streptococcus B, or culture negative,
respectively).There was no difference between the subgroups
in the incidence of urinary tract infection, wound infections,
or bacteremia, as shown in Table 2.
The 18 endometritis cases in the Streptococcus G or C
group were further analyzed and the data are shown in
Table 3. Commonly, the symptoms (foul smelling lochia,
abdominal pain, and fever) started 3–10 days after vaginal
delivery, and leukocytosis and a raised CRP value were
present. 67% (12/18) of patients were given intravenous
antibiotics, and the mean highest C-reactive protein (CRP)
was 122mg/L (range 8–267mg/L). After 7–10 days of com-
bined antibiotic treatment (cephalexin, metronidazole), the
patients recovered promptly and there were no complica-
tions. There were no clustering or outbreaks of endometri-
tis in local community during the study period, and the
endometritis cases were distributed evenly during the entire
study period.
Neonatal infections, antibiotic treatment for newborns,
and the need for neonatal intensive care unit treatment are
shown in Table 4. There was no difference between the
subgroups in terms of severe neonatal infections among the
1277 newborns, but there were more mild infections and
a nonsignificant tendency for more antibiotic treatment in
neonates whose mothers were Streptococcus B-positive.
4. Discussion
In this study, we found a clear association between the
colonization of SDSE and postpartum endometritis. This is
a novel observation, as there are very limited data published
previously about the outcome of SDSE colonization among
pregnant woman. In the past few years, there have been
many articles that assume Streptococci G and C have a
growing importance as clinically significant pathogens, but
the association between SDSE colonization and puerperal
endometritis has not yet been studied by other groups.
Prophylactic antimicrobial therapy during labor may
have affected the incidence of postpartum infections in the
groups. Streptococcus B-positive parturients were scheduled
to be administered antibiotics, and most of the women were
treated according to the guidelines. At least part of those
delivering without antimicrobial treatment had a rapid birth,
so there was not enough time to start antibiotic treatment
prior to the birth. Prophylactic antimicrobial treatment,
aimed at reducing the incidence of neonatal Streptococcus
B infections, probably also diminished maternal infectious
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Table 2: Postpartum maternal infections in the study groups.
Infection Streptococcus G or C Streptococcus B Negative p value
𝑛 (%) 𝑛 (%) 𝑛 (%)
Endometritis 18 (4.2) 3 (0.7) 1 (0.2) <0.001
Urinary tract infection 2 (0.5) 1 (0.2) 1 (0.2) 1.00
Wound infection 3 (0.7) 2 (0.5) 2 (0.5) 1.00
Bacteremia 1 (0.2) 1 (0.2) 0 (0.0) 1.00
Any infection 24 (5.7) 7 (1.7) 4 (1.0) <0.001
Differences between three study groups were assessed using Fishers exact test.
16 106
deliveries
15 144
vaginal cultures
11 744
negative cultures
421 control groups
2957
Streptococcus B-
positive cultures
421 control groups
443
Streptococcus G or
C-positive cultures
421 research groups
22 Streptococcus 
B-positive cultures 
excluded 
Figure 1: Flow diagram of the study participants (total 𝑛 = 1263).
morbidity [17]. In the Streptococcus G or C group, more
women received antimicrobial therapy during labor than
those who had negative cultures. According to our estima-
tion, besides antibiotics for suspected chorioamnionitis or
prophylaxis during cesarean section, some 16% (67/421) of
women incorrectly received prophylactic antibiotics in this
group due to a misunderstanding of guidelines. In those
cases, midwifes or doctors assumed that SDSE colonization
in the swab culture also warrants prophylactic antibiotic
treatment. It is noteworthy that postpartum endometritis was
significantly more frequent in this group even if antimicro-
bial treatment during labor was more frequent. This may
strengthen the conclusion that Streptococcus G or C is an
important risk factor for postpartum infections.
There is still not enough evidence to recommend pro-
phylactic antibiotic use for patients with SDSE colonization
during labor. However, antibiotic treatment should start
without delay for these women if other risk factors or signs
of infection appear during labor or in the postpartum period.
Because pregnancy alters the immune response, there is an
increased risk for infections. In 2014, Acosta et al. reported
on 365 cases of severe ante- and postpartum sepsis in the UK.
The source of infection was the genital tract in 31% of cases,
and 5.7% of infections were caused by Streptococcus G or C.
2.8% of the patients in that group had severe sepsis with septic
shock [18]. Additionally, after the study period, we have had a
few septic puerperal infections with a positive vaginal culture
of Streptococcus G or C, including two cases of group G or
C Streptococcus bacteremia. Both of these women had a long
labor as an additional risk factor for puerperal infection.This
strengthens the recognition of the potential pathogenicity
of these bacteria. SDSE can no longer be considered simply
a part of the normal microbiota; it is also an opportunist
pathogen to pregnant woman.
We did not find a difference between the subgroups in
severe neonatal infections (bacteremia or sepsis) in this study.
Interestingly, in our data, the neonates of mothers colonized
by Streptococcus B tended to receive more antibiotics than
newborns in the other two groups, despite the fact that their
mothers had already received antibiotic prophylaxis during
the delivery. Although this was not a statistically significant
finding, the result suggests that pediatricians are more likely
to start antibiotics if themother is known to be Streptococcus
B-positive. Streptococcus B is the most common pathogen
for early-onset neonatal sepsis, affecting 43–58% of cases, and
the diagnosis of sepsis is challenging because many other
noninfectious conditions resemble sepsis [19–21].
This study has some limitations. Some mild postpartum
infections after delivery may have been treated at a primary
care institution and as such could not be included in the
study data, which was collated from hospital inpatient and
outpatient material. Furthermore, it is possible that the
colonization status had changed before the delivery, because
in our protocol the rectovaginal swabs were obtained only
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Table 3: Case by case analysis of the Streptococcus G or C positive patients with endometritis.
Patient Mode ofdelivery
Gestational
age
Days from
delivery to
first
symptoms
Leukocyte
(max.)
CRP
(max.)
i.v
antibiotics∗
p.o
antibiotics∗ Infant
1 vaginal 42+1 10 13.1 59.5 - 7–10 No signs of infection. CRP 4.7, leuk 16.
2 vaginal 41+1 12 15.3 8.0 - 7–10 No signs of infection. CRP 3.3, leuk 12.7.
3 vaginal 37+3 5 18 225 5 7 No signs of infection. No laboratory tests.
4 acute CS 35+5 6 16.4 267 8 7 No signs of infection. No laboratory tests.
5 vaginal 38+2 7 17.4 11.8 - 7–10 No signs of infection. No laboratory tests.
6 vaginal 40+0 12 5.9 13.7 - 7–10 No signs of infection. CRP 2.7, leuk 13.3.
7 vaginal 39+6 3 10.8 173 2 7 No signs of infection. No laboratory tests.
8 plannedCS twins 37+2 20 3.3 234 3 7
A: NICU 9 days, iv. G-pen + Tomycin. CRP 39,
Neutropenia.
B: NICU 15 days, iv G-pen + Tomycin. CRP 36,
Neutropenia.
9 vaginal 40+5 3 13.0 94.9 3 7 No signs of infection. CRP 9.2, leuk 17.6.
10 vaginal 39+4 5 13.0 70.5 5 7 No signs of infection. CRP < 1, leuk 11.7.
11 vaginal 39+6 5 14.7 102 3 7 No signs of infection. No laboratory tests.
12 vaginal 41+0 3 14.8 146 2 10 No signs of infection. No laboratory tests.
13 vaginal 39+3 4 8.6 182.9 3 7 No signs of infection. No laboratory tests.
14 vaginal 41+0 4 14.2 159 4 7 No signs of infection. CRP 5.1, leuk 22.6.
15 vaginal 39+3 4 14 96.7 4 7 No signs of infection. No laboratory tests.
16 vaginal 35+4 12 8.9 56 - 7–10 No signs of infection. CRP 1.6, leuk 18.4.
17 vaginal 40+4 4 16.1 146 - 7–10 No signs of infection. CRP 3.1, leuk 21.4.
18 vaginal 37+1 4 16.9 147 3 7 No signs of infection. No laboratory tests.
∗Duration (days). I.v. antibiotics = intravenous antibiotic treatment, usually cefuroxime 1.5 g and metronidazole 500mg three times per day. P.o. antibiotics
= orally antibiotic treatment, usually cephalexin 500mg and metronidazole 500mg three times per day. CS, cesarean section; CRP, C-reactive protein; leuk,
leukocyte; NICU, neonatal intensive care unit.
Table 4: Neonatal infections and antibiotic and intensive care treatment in the study groups.
Streptococcus G or C Streptococcus B Negative
𝑝value
𝑛 (%) 𝑛 (%) 𝑛 (%)
Bacteremia, sepsis 0 (0) 0 (0) 1 (0.2) 1.00
Other infections∗ 28 (6.6) 40 (9.5) 19 (4.5) 0.015
Antibiotic treatment 35 (8.3) 45 (10.7) 28 (6.7) 0.103
NICU 40 (9.5) 51 (12.1) 38 (9.0) 0.272
∗Other infections are skin, urinary tract, navel infections, or suspicion of infections; NICU, neonatal intensive care unit; differences between three study groups
were assessed using Fisher’s exact test.
once between the 35th and 37th weeks of gestation. However,
with regard to previously published data, we can assume that
this does not change our results significantly. In 2015, Kunze
et al. found that the positive predictive value of a positive
prepartum screening result for Streptococcus B positivity
at delivery is over 77%. Their dataset included more than
900 patients, and the maternal Streptococcus B colonization
rates were similar when comparing pre- and intrapartum
screening [22]. A later timepoint for the swab could provide
even more up-to-date knowledge of the colonization during
the labor. On the other hand, late preterm or early term
laborswould happenwithout the knowledge of Streptococcus
colonization, and that would increase antibiotic use among
these parturients. In some units, an intrapartum group B
Streptococcus screening is used in the labor ward. In a study
by Plainvert et al., this method found 78% of the positive
cases, where the Streptococcus B culture was taken on the
labor ward [23].
We did not take rectovaginal swabs or other lochia cul-
tures to confirm the diagnosis during the puerperal period.
This is another weakness of our study.Thus, it is possible that
the woman had also been colonized by some other bacteria.
Our study is the first to report the association of SDSE
colonization and postpartum endometritis. A major strength
of this study is the large dataset, which covers 421 Strepto-
coccus G- or C-positive pregnancies. The subgroups were
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comparable. In the study population, the attendance rate for
rectovaginal swab screening was approximately 95%, which
makes our data more reliable. Le Doare et al. recently exam-
ined the Streptococcus B screening policies of 95 countries.
Themedian coverage was 80%, and 58% of the countries used
microbiological screening [24].
There is a distinct need for new studies to discover
whether the colonization of SDSE requires intrapartum
antibiotic prophylaxis. There were more postpartum infec-
tions in our study group, but there were no differences in
neonatal infections. At least in cases with additional risk
factors for puerperal infection, antimicrobial therapy should
be commenced after cutting the umbilical cord, or even
earlier during labor.
5. Conclusions
2.9% of pregnant women are colonized by Streptococcus
G or C. Vaginal colonization is associated with increased
risk of postpartum endometritis. More research is needed to
clarify if antibiotic prophylaxis is reasonable for this group,
but antibiotic treatment should start without delay for these
women if signs of infection appear during labor or in the
postpartum period.
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